$TIVC News
Last published 6mo ago
- 6mo agoTIVCTivic Health Systems Rebrands as Valion Bio, Reflecting Completed Transformation into a Late-Stage Biopharmaceutical Company with Government-Backed Asset and Potential Multiple Revenue Stream ModelPR NewswireTivic Health Systems, Inc. (Nasdaq: TIVC) today announced it is changing its corporate name to Valion Bio, Inc. and its Nasdaq ticker symbol from...
- 7mo agoTIVCTivic Health Selected to Present Entolimod™ as a Radiation Countermeasure and its Plans for an Oral Transmucosal Program to the Department of War Tech Watch Program on May 7thPR NewswireTivic Health Systems, Inc. (Nasdaq: TIVC), a clinical-stage immunotherapeutics company, today announced it has been selected to present at the U.S....
- 7mo agoTIVCTivic Receives Formal Request for Information from Ukrainian Ministry of Health Regarding Strategic Stockpiling of EntolimodACCESS NewswireSAN ANTONIO, TX / ACCESS Newswire / March 31, 2026 / Tivic Health Systems, Inc. , a clinical-stage immunotherapeutics company, today announced it has received a formal Request for Information from the
- 7mo agoTIVCTivic CEO To Present at the Upcoming Emerging Growth's April 2026 Virtual ConferenceACCESS NewswirePresentation will Cover Recent Corporate Milestones Including Securing Agreement with NIAIDSAN ANTONIO, TX / ACCESS Newswire / March 27, 2026 / Tivic Health® Systems, Inc. , a clinical-stage
- 7mo agoTIVCTivic Secures NIAID Non-Clinical Evaluation Agreement for Entolimod, Targeting Gastrointestinal Acute Radiation SyndromeACCESS NewswireArmed Forces Radiobiology Research Institute Will Conduct the Gastrointestinal Acute Radiation Syndrome StudySAN ANTONIO, TX / ACCESS Newswire / March 26, 2026 / Tivic Health Systems Inc. ,
- 7mo agoTIVCTivic Reports Full Year 2025 ResultsACCESS NewswireCompletes Strategic Transformation into an Immunotherapy Company and Continues to Advance Entolimod Platform Toward Potential Funding PartnershipsConference Call to be Held Today at 1:30 PM PT / 4:30 PM ETSAN ANTONIO, TX
- 7mo agoTIVCTivic Health CEO Letter to ShareholdersACCESS NewswireSAN ANTONIO, TX / ACCESS Newswire / March 24, 2026 / Tivic Health Systems Dear Valued Shareholders,As I assume the role of Chief Executive Officer at Tivic, my immediate priority is to establish a
- 7mo agoTIVCTivic To Report 2025 Year-End Financial Results Via Conference Call and Webcast on March 25th at 1:30pm PT / 4:30pm ETACCESS NewswireSAN ANTONIO, TX / ACCESS Newswire / March 20, 2026 / Tivic Health Systems, Inc. , a late-stage immunotherapeutics company, today announced that it will report its year-end financial results for 2025 via
- 8mo agoTIVCBiotech Veteran Michael K. Handley Named CEO of Tivic Health Systems to Spearhead Strategic Expansion in BiopharmaACCESS NewswireSAN FRANCISCO, CA / ACCESS Newswire / March 4, 2026 / Tivic Health Systems, Inc. , a late-stage immunotherapeutics company, today announced that its Board of Directors has
- 8mo agoTIVCTivic and BARDA Continue Discussions of Entolimod for Acute Radiation Syndrome on March 10ACCESS NewswireInitial presentation on January 26, 2026 showcased Entolimod's potential to mitigate and prevent both gastrointestinal and hematopoietic injury from ionizing radiation exposure.FREMONT, CA / ACCESS Newswire / February
- 9mo agoTIVCTivic, BARDA Discuss Entolimod(TM) for Acute Radiation Syndrome at TechWatch MeetingACCESS NewswireJanuary 26 Presentation highlighted Entolimod's potential to mitigate and prevent both gastrointestinal and hematopoietic injury from ionizing radiation exposureBARDA has requested a follow-up meeting to continue the
- 9mo agoCBBHFCEIEFCLNNCOPAF+26Presenting on Emerging Growth Conference 89 Day 1 on January 21; Register to live streamGlobeNewswireMIAMI, Jan. 20, 2026 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 89th Emerging Growth Conference on January 21 & 22, 2026. The Emerging Growth
- 11mo agoTIVCTivic Acquires Ready-to-Scale cGMP Manufacturing and Development Assets to Accelerate Commercialization of Entolimod; Tivic Growth Backed By $90M+ Financing PackageACCESS NewswireAcquisition creates additional near-term revenue opportunities from newly formed Contract Development and Manufacturing Organization subsidiary, Velocity Bioworks™Financing led by 3i, LP includes $16M debt
- 11mo agoTIVCTivic Secures Barda Meeting for Entolimod(TM) for Acute Radiation SyndromeACCESS NewswireMeeting with Radiological and Nuclear Medical Countermeasures Program FREMONT, CA / ACCESS Newswire / November 18, 2025 / Tivic Health® Systems, Inc. , a late-stage therapeutics company, today announced
- 12mo agoTIVCTivic Reports Third Quarter 2025 Financial ResultsACCESS NewswireContinues Execution of Strategic Transformation and Advancement of Biologics Pipeline FREMONT, CA / ACCESS Newswire / November 14, 2025 / Tivic Health® Systems, Inc. , a diversified immunotherapeutics
- 12mo agoTIVCTivic Health Reports Findings of Clinical Optimization Trial of Non-Invasive Cervical Vagus Nerve Stimulation (ncVNS)ACCESS NewswireThe study demonstrated that personalizing the stimulation parameters to each user dramatically enhanced autonomic effects FREMONT, CA / ACCESS Newswire / November 13, 2025 / Tivic Health Systems, Inc. , a
- 1y agoTIVCTivic Expands Intellectual Property PortfolioBusiness WireNew Biologics Patent Application Covers Potential Applicability of TLR5 Agonists to Improve Outcomes for Late-stage Cancer Therapies; Bioelectronic Patent Covers Optimized ncVNS Device Specifications Tivic
- 1y agoTIVCTivic Health to Report Third Quarter 2025 Financial Results on November 14th Via Conference Call and WebcastBusiness WireTivic Health® Systems, Inc. (NASDAQ:TIVC), a diversified immunotherapeutics company, today announced that it will report its third quarter results for 2025 via pre-recorded conference call and webcast on Friday,
- 1y agoTIVCTivic CEO, Jennifer Ernst, to Join Panel at 8th Annual Northwell Health Innovation Constellation Forum on Thursday, Oct. 23Business WireTivic Health® Systems, Inc. (NASDAQ:TIVC), a diversified immunotherapeutics company, today announced that CEO, Jennifer Ernst, will participate in the eighth annual Constellation Forum, a global conversation on
- 1y agoTIVCTivic Health CEO Jennifer Ernst to Present at Emerging Growth's September Virtual ConferenceBusiness WireTivic Health® Systems, Inc. (NASDAQ:TIVC), a diversified immunotherapeutics company, today announced that the company's CEO will present during the Emerging Growth virtual conference set to take place on September
- 1y agoTIVCTivic Completes Verification of Entolimod™ Cell Line: First Step in Establishing CGMP Manufacturing for BLA FilingBusiness WireTivic Health® Systems, Inc. (NASDAQ:TIVC), a diversified immunotherapeutics company, today announced that it has completed verification of its Entolimod™ cell line, the first step in establishing Current
- 1y agoTIVCTivic Receives Two Investigational New Drug Applications for Entolimod™ for the Treatment of Acute Radiation Syndrome (ARS) and Advanced CancersBusiness WireINDs Transferred from Statera Biopharma Advance Entolimod for ARS Along Regulatory Pathway and Enable Pursuit of Clinical Trial Program in Neutropenia and Lymphocyte Exhaustion Tivic Health® Systems, Inc.
- 1y agoTIVCTivic Health Advances Discussions on Use of Entolimod as a Radiation Countermeasure at Military Health System Research Symposium 2025Business WireTivic Health® Systems, Inc. (NASDAQ:TIVC), a diversified therapeutics company, is proud to announce it advanced discussions with key US Government agencies through its participation in the 2025 Military Health
- 1y agoTIVCTivic Health Systems, Inc. (TIVC) Q2 2025 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoTIVCTivic Reports Second Quarter 2025 Financial ResultsBusiness WireCompany advances its TLR5 agonist program and prepares to report VNS clinical data Tivic Health® Systems, Inc. (NASDAQ:TIVC), a diversified immunotherapeutics company, today announced financial results for the
- 1y agoTIVCTivic Health to Report Second Quarter 2025 Financial Results on August 14th Via Conference Call and WebcastBusiness WireTivic Health® Systems, Inc. (NASDAQ:TIVC), a diversified immunotherapeutics company developing treatments that stimulate immune pathways to treat disease, today announced that it will report its second quarter
- 1y agoTIVCTivic Shareholders Approve Key Proposals in Support of Strategic Transformation; Lisa Wolf Appointed Permanent CFOBusiness WireCompany provides additional management updates Tivic Health® Systems, Inc. (NASDAQ:TIVC), a diversified immunotherapeutics company, today announced that key proposals needed to carry out the company's strategic
- 1y agoTIVCTivic Health Completes Optimization Study for Its Non-Invasive Vagus Nerve Stimulation DeviceBusiness WireBreakthrough Findings to be Reported Later this Year and Applied to Upcoming Phase I Clinical Trial Tivic Health® Systems, Inc. (NASDAQ:TIVC), a diversified immunotherapeutics company developing treatments that
- 1y agoTIVCTivic Health Announces 2025 Annual Meeting of StockholdersBusiness WireTivic Health® Systems, Inc. (NASDAQ:TIVC), a diversified therapeutics company, announced today its Virtual Annual General Meeting of Shareholders will be held on Monday, June 30, 2025 at 1:00 PM, Pacific Time
- 1y agoADIAATNMBPTHCNVIF+12Life Sciences Investor Forum: Now Available for Online ViewingGlobeNewswireNEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Life Sciences Investor Forum, held June 11th and
- 1y agoADIAATNMBPTHCNVIF+12Life Sciences Investor Forum Agenda Announced for June 11th-12thGlobeNewswireNEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series announced the agenda for the Life Sciences Investor Forum June 11th & 12th. This event is
- 1y agoTIVCTivic Reports First Quarter 2025 Financial Results and Provides Updates on Business TransformationBusiness WirePre-recorded Conference Call to Follow at 1:30 p.m. PDT/4:30 p.m. EDT Tivic Health® Systems, Inc. (NASDAQ:TIVC), a diversified immunotherapeutics company, today announced financial results for the first quarter
- 1y agoTIVCTivic Expands VNS Intellectual Property PortfolioBusiness Wire- New patent protects methods for increasing efficacy via personalization of stimulation parameters and electrode positioning - Tivic Health® Systems, Inc. (NASDAQ:TIVC), a diversified therapeutics company,
- 1y agoTIVCTivic Health to Report First Quarter 2025 Financial Results on May 15th Via Conference Call and WebcastBusiness WireTivic Health® Systems, Inc. (NASDAQ:TIVC), a diversified therapeutics company harnessing the power of the immune and autonomic nervous systems to fight disease and restore health, today announced that it will
- 1y agoTIVCTivic Health Reports White House Briefing and FDA Meetings Secured Positive Interest in Potential Military and Defense Applications of Its Product CandidatesBusiness WireSenior Level Meetings Included Discussion of Tivic's TLR5 and Vagus Nerve Stimulation Programs Tivic Health® Systems, Inc. (NASDAQ:TIVC), a diversified therapeutics company, announced today that it provided
- 1y agoTIVCTivic Health Extends its Worldwide License of TLR5 Agonist Entolimod to Include the Treatment of NeutropeniaBusiness WireTivic Health Systems, Inc. (NASDAQ:TIVC), a diversified therapeutics company, today announced that, on March 28, 2025, it exercised its licensing option for the exclusive, worldwide rights to advance Entolimod™
- 1y agoTIVCTivic Health Systems, Inc. Regains Compliance with NASDAQ Minimum Bid Price Listing RuleBusiness WireTivic Health® Systems, Inc. (NASDAQ:TIVC), a diversified therapeutics company, announced today that it has received confirmation from Nasdaq that the Company has regained compliance with the minimum bid
- 1y agoTIVCTivic Reports Year End 2024 Financial Results and Provides Overview of Strategy for Transformation and GrowthBusiness WirePre-recorded Conference Call and Webcast to Follow Today at 1:30 PM PDT / 4:30 PM EDT Tivic Health® Systems, Inc. (NASDAQ:TIVC), a diversified therapeutics company, today announced year end December 31, 2024
- 1y agoTIVCTivic Health to Report 2024 Year-End Financial Results on March 21st Via Conference Call and WebcastBusiness WireTivic Health® Systems, Inc. (("Tivic Health", NASDAQ:TIVC), a diversified therapeutics company harnessing the power of the immune and autonomic nervous systems to fight disease and restore health, today announced
- 1y agoTIVCTivic Health and Feinstein Institute Present New Data Showing Personalized Vagus Nerve Stimulation Method Optimizes Impact on Autonomic Nervous SystemBusiness WireAdvances Tivic's Development of Non-Invasive VNS Devices Aimed at Treating Inflammatory, Cardiac and Neurologic Disorders Tivic Health® Systems, Inc. (NASDAQ:TIVC), a diversified therapeutics company, announced
- 1y agoTIVCTivic Health Systems, Inc. Announces Reverse Stock SplitBusiness WireTivic Health® Systems, Inc. (NASDAQ:TIVC) ("Tivic Health" or the "Company), a diversified therapeutics company, announced today that its Board of Directors has declared a 1-for-17 reverse stock split of the
- 1y agoTIVCTivic Health Files Patent For Optimized Electrical Stimulation of the Vagus NerveBusiness Wire- Patent based on state-of-the-art science of vagus nerve stimulation approach shows greater effect from personalization of treatment - Tivic Health® Systems, Inc. (NASDAQ:TIVC), a diversified therapeutics
- 1y agoTIVCTivic Health Names Biotech Industry Veteran Michael K. Handley to Executive Leadership TeamBusiness WireHandley Joins as President of Tivic Biopharma and Chief Operating Officer of Tivic Health Following Its Licensing of Strategic Biopharma Assets From Statera Biopharma Tivic Health® Systems, Inc. (NASDAQ:TIVC), a
- 1y agoTIVCCEO Letter to Shareholders Issued by Tivic HealthBusiness WireProvides updates on vagus nerve stimulation (VNS) program and expectations for 2025 Tivic Health® Systems, Inc. (NASDAQ:TIVC), a health tech company developing and commercializing bioelectronic medicine, today
- 1y agoTIVCTivic Reports Third Quarter 2024 Financial Results and Provides Business UpdateBusiness WirePre-recorded Conference Call to Follow at 1:30 p.m. PDT/4:30 p.m EDT Tivic Health® Systems, Inc. (NASDAQ:TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced third
- 1y agoTIVCTivic Health Systems, Inc. (TIVC) Q3 2024 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoTIVCEnrollment Complete in Tivic Health Optimization Study for its Non-Invasive Vagus Nerve Stimulation DeviceBusiness WireTivic Health® Systems, Inc. (NASDAQ:TIVC), a health tech company developing and commercializing bioelectronic medicine, announced today that full enrollment has been completed in the optimization study for Tivic
- 1y agoTIVCTivic Health Validates European Patents in Great Britain, Germany, and FranceBusiness WirePatents cover methods used to identify key treatment points and dynamically personalize simulation Tivic Health® Systems, Inc. (NASDAQ:TIVC), a health tech company developing and commercializing bioelectronic
- 2y agoTIVCTivic Health Systems, Inc. to Report Third Quarter 2024 Financial Results on November 14Business Wire– Conference Call and Webcast to Follow at 1:30 p.m. PST/4:30 p.m. EST - Tivic Health® Systems, Inc. (NASDAQ:TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced it
- 2y agoTIVCFirst Subject Enrolled in Tivic Health's Optimization Study for its Non-Invasive Vagus Nerve Stimulation DeviceBusiness WireTivic Health® Systems, Inc. (NASDAQ:TIVC), a health tech company developing and commercializing bioelectronic medicine, announced today that the first study subject has been enrolled in the optimization study for